Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
32.24 EUR | -1.36% |
|
+1.55% | -0.66% |
25/06 | Halozyme Therapeutics Says Roche's OCREVUS SC With ENHANZE Gets European Commission Approval | MT |
25/06 | Roche: approval of Ocrevus SC in Europe | CF |
Official Publications
No official publication found
- Stock Market
- Equities
- ROG Stock
- RHO6 Stock
- News Roche Holding AG
- Official Publications